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Abstract 
OBJECTIVE: Examination of the skin barrier repair/wound healing process using a living skin 
equivalent (LSE) model and matrix-assisted laser desorption/ionization-mass spectrometry imaging 
(MALDI-MSI) to identify lipids directly involved as potential biomarkers. These biomarkers may be 
used to determine whether an in vivo wound is going to heal for example if infected. 
METHODS: An in vitro LSE model was wounded with a scalpel blade and assessed at day 4 post 
wounding by histology and MALDI-MSI. Samples were sectioned at wound site and were either 
formalin fixed paraffin embedded (FFPE) for histology or snapped frozen (FF) for MSI analysis. 
RESULTS: The combination of using an in vitro wounded skin model with MSI allowed the 
identification of lipids involved in the skin barrier repair/wound healing process. The technique was 
able to highlight lipids directly in the wound site and distinguish differences in lipid distribution 
between the epidermis and wound site. 
CONCLUSION: This novel method of coupling an in vitro LSE with MSI allowed in depth molecular 
analysis of the skin barrier repair/wound healing process. The technique allowed the identification of 
lipids directly involved in the skin barrier repair/wound healing process, indicating these biomarkers 
may be potentially be used within clinic. These biomarkers will help determine, which stage of the 
skin barrier repair/wound healing process the wound is in to provide the best treatment. 
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Introduction 
Damage to the structural integrity of the skin through trauma or injury initiates the skin barrier 
repair/wound healing process, which is highly complex and carefully regulated with ordered 
responses [1]. There are four main stages involved in the normal skin barrier repair/wound healing 
process: haemostasis, inflammation, proliferation, and remodelling, all of which occur in an 
overlapping chronological sequence as shown in Fig. 1 [2]. Disruption to the sequence or 
prolongation in the inflammation stage has been shown to delay the skin barrier repair/wound 
healing process, leading to non-healing chronic wound formation. Chronic wounds have been 
described as wounds, which do not heal within 3 months from the time of injury [3]. Several factors 
have been shown to affect the progression of the normal skin barrier repair/wound healing process, 
including infection, age, diabetes and obesity [4]. The prevalence of chronic wounds has been 
described as a silent epidemic, affecting a large proportion of the world population, particularly 
western societies, where 1-2% of the population will develop a chronic wound [5]. Treating and 
managing these wounds creates major problems for health budgets in the western world, where a 
total cost of 2–4% is spent caring for people suffering from these wounds [5]. These health problems 
cause a huge drain on wound care management resources and in 2014 the UK’s National Health 
Service spent approximately £2.17 billion on wound care services [6]. Unfortunately, the health 
budgets in western countries are expected to rise annually, as a natural consequence of ageing 
populations and an increase of people suffering from diabetes and obesity. Severe pain, sepsis, 
hospitalisation, and in some cases amputations are factors affecting patients with chronic wounds 
[7]. Research has suggested that better diagnosis and wound management may prevent chronic 
wound formation [8]. This paper reports the creation of in vitro 3D wounded skin models using living 
skin equivalent (LSE) models. These are easily manipulated to create wounds in a controlled 
environment. The use of matrix assisted laser desorption ionisation-mass spectrometry imaging 
(MALDI-MSI) to study these wound models provides the opportunity for unlabelled multi-analyte 
detection capable of analysing a wide range of molecules simultaneously, whilst assessing the spatial 
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distribution of molecules in biological tissues [9]. In this paper a wounded LSE model was combined 
with MALDI-MSI to discover and identify biomarkers specific to the skin barrier repair/wound 
healing process. These biomarkers have the potential to be applied within clinics as an early 
diagnostic tool to help identify whether a wound is healing or developing into a chronic wound. 
Materials and methods 
Incision wound protocol 
The incision model was created using a commercial LSE model (Labskin, Innovenn UK Ltd., UK) at day 
12 air-liquid interface. Each sample was wounded three times with a scalpel blade (No 10, Swann-
Morton, UK) at controlled penetration wounding the epidermal and dermal layers. Samples were 
assessed at day 4 post wounding. 
Media was changed every 2 days with Labskin maintenance medium (Innovenn UK Ltd., UK) up to 4 
days post wounding. 
Fresh frozen tissue and cryosectioning 
At day 4, samples were removed from the well plate inserts, detached from the membrane and cut 
in half across the wound site and embedded in 20% gelatine (Sigma Aldrich, UK) within a silicone 
mould (Truffly Made Inc., USA). The silicone mould was placed directly on a polystyrene float in a 
polystyrene box containing liquid nitrogen. The samples were removed from the mould once snap 
frozen and stored at −80°C for at least 24 hours prior to sectioning. Each sample was divided into 
two and each half was mounted onto cork rings with deionised water at −25°C. Samples were 
cryosectioned at 10 µm directly across the wound site and freeze-thaw mounted onto either 
polylysine coated microscope slides (SLS, UK) for analysis on either the Waters Synapt G2 HDMS or 
the Applied Biosystems QSTAR Pulsar i mass spectrometers or indium titanium oxide (ITO) coated 
slides for analysis on the Bruker Autoflex III mass spectrometer.  
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Formalin fixed paraffin embedded (FFPE) tissue and sectioning 
Samples were fixed with 10% neutral buffered formalin (Genta Medical, UK) and processed using a 
dehydration series in different concentrations of industrial denatured alcohol (IDA, Genta Medical, 
UK) each for 1 hour (70%, 80% and 90%) and then 100 % IDA for 1 hour (x3), xylene substitute for 1 
hour (x3) and then paraffin wax at 58°C for 1 hour (x2). Samples were embedded in paraffin wax and 
sectioned at 5 µm using a microtome HM 325 (Thermo Fisher, UK) onto microscope slides. Samples 
were left in a 50°C oven overnight prior to staining. 
Haematoxylin and eosin staining 
FFPE samples slides were placed in xylene substitute for 5 minutes twice, 100% IDA for 3 minutes 
twice and rinsed with tap water for 5 minutes. Slides were transferred to Harris haematoxylin (Cell 
Path, UK) for 10 minutes, rinsed with tap water for 2 minutes and then dipped into 1:1 v/v 0.5% acid 
alcohol: 70% IDA for 3 seconds. Slides were then rinsed for 3 minutes with tap water, placed in 
Scott's tap water for 1 minute and then rinsed with tap water for 3 minutes. The slides were 
transferred to eosin y solution for 3 minutes and then rinsed with tap water for 2 minutes. Slides 
were dipped into 70% IDA for 3 seconds, transferred to 100% IDA for 3 minutes twice and then 
xylene substitute for 3 minutes twice.  Samples were mounted with DPX and imaged using a Leica 
DM2000 microscope fitted with 4x, 10x, 20x, 40x and 100x objectives and analysed with Leica LAS X 
software (Germany). 
Fresh frozen tissue samples were washed with 100% acetone for 5 minutes twice and then rinsed 
with tap water for 5 minutes. The same protocol was followed as described above after transferring 
the samples to Mayers haematoxylin (VWR) for 10 minutes to mounting the samples with DPX. 
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Small-molecule MALDI-MS imaging  
Positive ion mode 
Sections were coated with MALDI matrix (α-cyano-4-hydroxycinnamic acid (CHCA, Sigma Aldrich, 
UK), 5 mg/mL in 70:30 acetonitrile: 0.5% TFA) using a SunCollect (SunChrom Friedrichsdor, Germany) 
sprayer. Slides were coated with 8 layers of CHCA matrix, spraying at 4 µL/min for the first layer and 
then 3.5 µL/min for the subsequent 7 layers. Mass spectra was collected on an Applied 
Biosystems/MDS Sciex hybrid quadrupole TOF mass spectrometer (QSTAR Pulsar i) with an 
orthogonal MALDI ion source (Applied Biosystems, Foster City, CA, USA) and a high-repetition 
neoddymium-doped yttrium aluminium garnet (Nd:YAG) laser (355 nm, 1 KHz) (Applied Biosystems, 
USA). Image acquisition was performed at a pixel size of 75 µm × 75 µm in “Raster Image” mode with 
mass range of 400-1200 Da. Images were generated using the freely available Novartis Biomap 
3.8.0.4 software (www.maldi-msi.org). Prior to analysis the instrument was calibrated using CHCA 
matrix peak cluster ions. 
 
Negative ion mode for Imaging 
Sections were coated with MALDI matrix (N-(1-naphthyl) ethylenediamine dihydrochloride 
monomethanolate (NEDC, Sigma Aldrich, UK), 7 mg/mL in 1:1 methanol: deionised water) using a 
SunCollect (SunChrom Friedrichsdor, Germany) sprayer. Slides were coated with 6 layers of NEDC 
matrix, spraying each layer at 3.5 µL/min. Mass spectra was collected on a Bruker Autoflex III fitted 
with a “Smartbeam” Nd:YAG laser (355 nm, 1 KHz) (Bruker, Germany). Image acquisition was 
performed at a pixel size of 30 µm × 30 µm in “Raster Image” mode with mass range of 400-1200 Da.  
Prior to analysis the instrument was calibrated using the Bruker prepared mtp standard target 
peptide calibration mix 2. 
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Negative ion mode for MS/MS profiling 
Sections were coated NEDC as described above however, samples were analysed using a HDMS 
SYNAPT G2 HDMS system (Waters Corporation, UK) and Driftscope 2.1 software (Waters 
Corporation). MS/MS spectra were acquired by manually moving the laser position and adjusting the 
collision energy between 25-45 eV with acquisition times of 20 seconds per spectrum. MS/MS peak 
lists from each spectrum were uploaded onto LIPID MAPS (http://www.lipidmaps.org) for database 
search. Prior to analysis the instrument was calibrated using red phosphorous cluster ions. 
 
Results 
Mass spectrometry profiling and imaging of localised lipids 
The technique was used to assess the lipid distribution across the wounded sample with emphasis 
on three regions of interest (ROIs); i) the dermis, ii) the wound site and iii) the epidermis. The main 
area of interest was the wound site, which was compared against the dermis and the epidermis to 
determine lipid profile differences in the three ROIs. Fig. 2 shows the average mass spectra collated 
from each ROI showing m/z peaks of signals, which are potentially lipids in the m/z range 400-1200. 
This allowed for the creation of MS profile signatures, which were distinct between the dermis, 
wound site and epidermis. The spectra from the dermis layer exhibited a limited number of m/z 
peaks compared to the wound site and the epidermis. The results show similarities in the m/z values 
identified in the wound site and epidermal spectra. However, the wound site mass spectra exhibited 
a greater number of peaks in the lower mass range compared to those acquired from the epidermis. 
The haematoxylin and eosin (H&E) staining of the tissue showed that keratinocytes from the 
epidermis had migrated into the wound site, providing an explanation for the similarities in mass 
spectra acquired from the epidermis and the wound site (Fig. 3).  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
MS images of the distribution of (a) m/z 721.4 and 725.4 (as a bicolour overlay) and (b) m/z 751.6 
are shown in Fig. 3 from the tissue sample 4 days post wounding. In the images, the epidermis is 
clearly visible as a layer in the upper part of each image. Two out of three wound sites present in the 
sample can also been seen in the images and have been highlighted in Fig. 3 with black and white 
arrows. In Fig. 3a the ion distribution shown in the image in green represents a species with a m/z 
value of 721.4 and can be observed to localise in keratinocytes in the epidermis as well as in the 
wound site. Additionally, the ion shown in Fig. 3a in red (m/z 725.4) was only found in the dermis. 
Fig. 3b shows the spatial distribution of a single ion (m/z 751.6) and shows that the signal is 
predominately located within the healed wound site, by comparison with the H&E image of the 
same tissue (Fig. 3b inserts).  
Principal Component Analysis Principal component analysis-discriminant analysis 
To investigate whether there were distinct lipids from each region of interest, all the spectra collated 
from the tissue were subjected to principal component analysis (PCA) and principal component 
analysis-discriminant analysis (PCA-DA). A spectrum was collected at every single point as the laser 
was fired across the sample. Therefore, the spectrum contained all the information relating to all 
signal intensities of the ions within the selected mass range. A vast amount of information was 
collected from the whole tissue, creating a large dataset for each analysed sample. PCA reduced the 
dimensionality of the dataset allowing the data to be interpreted, whilst retaining all the statistical 
information. PCA-DA is a supervised variant of PCA and allowed groups to be discriminated using 
multiple observed variables (e.g. discriminating between dermis, wound site and epidermis) if 
unsupervised PCA was unable to distinguish statistical differences between the three regions of 
interest. Fig. 4 shows PCA and PCA-DA plots of 5 spectra datasets from each ROI (dermis, wound site 
and epidermis) in positive and negative ion mode. The spectra from each ROI were chosen by 
assessing the H&E image to select regions, which were distinct from each other. Fig. 4 (A-D) shows 
the PCA and PCA-DA scores plots obtained from these data. Fig. 4A shows PCA scores plot for 
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positive ion mode and showed there were differences in ions from the dermis (region highlighted in 
red), compared to the wound site and epidermis. However, there was very little variation between 
the wound site or epidermis (region highlighted in green). However, the PCA-DA scores plot (Fig. 4B) 
showed discrimination between the three ROIs, indicating there were distinct ions and potentially 
lipids associated with each area (red area for dermis, yellow area for wound site and blue area for 
epidermis). Fig. 4C shows the PCA scores plot conducted on spectra collected from the selected ROIs 
in negative ion mode and showed there were specific ions related to each ROI because it was able to 
separate the regions without group information. However, the spectrum from one dermis ROI was 
very dissimilar from the other dermis spectra. PCA-DA, shown in Fig. 4D was able to discriminate 
between all three regions of interest based on the ions within each ROI.  
Fig. 5 shows the PCA-DA scores and loadings plots from the negative ion data. Using the loadings 
plot, individual ions associated specifically with each region were identified. The PCA-DA allowed the 
individual ions isolated in each ROI to be compared against a lipid database based on its m/z value. 
Therefore, allowing putative identification of specific lipids in each region as shown in Table I.  
Several isobaric lipids were identified from each m/z value due to molecules possessing the same 
molecular mass, but different structures. Therefore, it was difficult to identify the exact lipid based 
on its m/z value alone without further investigation such as conducting tandem mass spectrometry 
(MS/MS) profiling.  
MS/MS profiling of putative lipids 
Eleven m/z values were selected from Table I where 4 represented the dermis, 4 from the epidermis 
and 3 from the wound site for MS/MS analysis. It was possible to identify 5 species based on their 
product ion spectra as shown in Table II. Four of the putative identified lipids belonged to the group 
of lipids called glycerophospholipids (e.g. phosphatidylethanolamines (PE), phosphatidylserines (PS), 
phosphatidylgylcerols (PG), phosphatidic acids (PA) and phosphatidylinositols (PI)) and were located 
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in the dermis and wound site. Whereas, a glucosylceramide (Glcβ-Cer) was found in the epidermis 
and wound site and belonged to a group of lipids called glycosphingolipids. 
Metabolite Pathway database searching 
Mass-to-charge ratios and averaged signal intensities from spectra of each ROI were submitted to 
Pathos, which is a database to identify metabolites in numerous metabolic pathways based on their 
m/z values. It was possible to compare spectra from the wound site against the dermis to highlight 
potential metabolites, which may be involved in the skin barrier repair/wound healing process as 
shown in Table III. The Pathos search found 14 metabolites involved in 9 different pathways with 
42% of them involved in the biosynthesis of unsaturated fatty acids and ubiquinone biosynthesis, as 
well as purine metabolism. All the metabolites identified in the pathways showed an increased 
change in signal intensity, indicating there was an increase in metabolite production and/or 
secretion in the wound site. 
Discussion 
Recently, there has been a vast amount of interest in the study of lipids, which has led to the 
development of a new emerging field of research called lipidomics [10]. This area of studying lipids 
includes the large scale quantitative and qualitative analysis of different lipid classes and individual 
lipid species [11]. Lipids are part of the metabolome and are fundamental and important in many 
cellular and organismal functions. Lipids primarily have four different functions; i) formation of  
membranes for the compartmentalisation of cells and organelles, ii) to act as an energy store and 
release energy when required for biological processes iii) regulation of biochemical reactions by 
inducing the interaction activity between proteins and transient and permanent membranes and iv) 
signalling [12]. Biological cells, which undergo physiological change, such as migration and 
proliferation, initiate major morphological and cellular changes including membrane changes. Lipids 
acting as the lipid bilayer of cells and organelles are in direct contact with changes in intracellular 
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and extracellular environments, which in turn result in chemical and structural changes in the lipids. 
The central dogma of molecular biology dictates that DNA makes RNA, which produce proteins (e.g. 
enzymes), which in turn make lipids, thus representing the phenome [12]. Therefore, lipids are 
becoming widely utilised as biomarkers for disease states, as changes in the lipidome provides 
insight into early biochemical anomalies or processes [13].  
Immediately after a breach of skin integrity when the physical barrier becomes disrupted, the skin 
barrier repair/wound healing process becomes activated to repair the damaged area to prevent 
pathogens/ harmful materials entering the body as well as prevent fluid loss [14]. The formation of a 
new epithelial layer over the wound, to re-establish the barrier function, has been described as one 
of the most important events in wound healing. Therefore, re-epithelialisation must occur quickly 
after damage to the skin to achieve the best healing outcome. Injury to the skin initiates a 
coordinated and ordered cascade of biological responses, which if not interrupted, progresses 
through all stages of the skin barrier repair/wound healing process [1]. Skin wound healing involves 
several overlapping stages, which include haemostasis, inflammation, proliferation, and re-modelling 
[4]. During the inflammation phase, which occurs immediately after injury, inflammatory cells 
(macrophages, neutrophils and monocytes) migrate to the wounded site via chemotactic signals 
[15]. Simultaneously, keratinocytes of the epidermis start to migrate, proliferate and differentiate to 
regenerate the epithelial layer across the damaged area [16]. Koivisto et al., suggested basal 
keratinocytes may migrate as a sheet along the wound provisional matrix [16]. 
Fig. 2 shows MS spectra acquired from the three different ROIs and differences in the signals 
associated with each region. The spectra collected from the dermis were very different from those 
collected from the wound site and epidermis. The epidermis and wound site spectra showed a 
greater number of analytes with greater signal intensity compared to the dermis. This may be due to 
the dermis consisting of fibroblasts, which are dispersed throughout the fibrin gel (which comprises 
the scaffold in this 3D cell model), compared to the keratinocytes of the epidermis, which are tightly 
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connected to one another. Therefore, a greater number of lipids present in the same area, provided 
a greater signal intensity. The spectra of the epidermis and wound site are also similar, because of 
the migration of keratinocytes into the wound site to close the damaged area. This is clearly 
observable in the H&E stained images of the sample (Fig 2 inserts). These observations are in 
agreement with previous studies where keratinocyte migration and proliferation was initiated during 
the early stages of wound repair.  
Mass spectrometry imaging visualises the distribution of endogenous molecules, within tissue 
samples, by reconstructing false-coloured images based on the intensity of mass-to-charge (m/z) 
signals against pixel locations across the whole sample. There were differences in the signals found 
in ROIs, as shown in the MS images (Fig. 3A-B).  Here specific m/z values could be used to visualize 
each area i.e. m/z 721.4 corresponded with the epidermis, m/z 725.4 correlated with the dermis and 
m/z 751.6 was shown to be specific to the wound site. 
PCA-DA of the spectra from each region of interest (Fig. 4 and Fig. 5) was able to highlight a number 
specific m/z values associated with either the dermis, epidermis or wound site. Using the identified 
m/z values in combination with database search gave putative lipid identification for each m/z value 
(Table I). However, since many different lipids may have the same molecular formula therefore, 
possessing the same m/z value further analyses of species of interest was conducted.  
MS/MS profiling was used to create lists of product ions for database search of the MS/MS spectra 
recorded from 11 m/z values of interest from Table I. From this data 5 putative lipids were identified 
as shown in Table II. Two glycerophospholipids (PA and PI) could be specifically associated with the 
dermis and two different glycerophospholipids (PE and PS) with the wound site/epidermis. 
Additionally, the wound site could be associated with a lipid which was part of the glycosylceramides 
class (Glcβ-Cer). Numerous studies have shown glucosylceramides are the glucosylated 
intermediates for the synthesis of ceramides, which are essential for producing lamellar structures 
mediating the epidermal permeability barrier function and skin homeostasis [17,18]. Wounding the 
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model disrupted the epidermis barrier function thus, stimulating keratinocytes to migrate and 
proliferate across the wound to close the damaged area. Therefore, the putative identification of 
glycosylceramides in the epidermis above the wound site may be associated with the keratinocytes 
repairing the wound and thus, involved in the skin barrier repair/wound healing process. These data 
suggest that glycosylceramides may be used as a biomarkers linked to early stage wound healing.  
The full scan MS data was also subjected to a metabolite search and analysis of accompanying 
metabolic pathways. Several metabolic pathways were identified as shown in Table III. The database 
found elevated signal intensities of 14 metabolites involved in 9 different metabolic pathways in the 
wound site, compared to the dermis. These results indicate increased metabolite signal intensity 
correlated with increased metabolite production, which may be associated with wound healing. 
Three of the metabolites that had elevated signal intensities were part of the biosynthesis of 
unsaturated fatty acids pathway and studies have shown fatty acids including omega-3 fatty acids 
accelerate the re-epithelialization process [19]. Additionally, 3 metabolites were identified in the 
ubiquinone synthesis pathway. Studies of coenzyme Q10, which is a biosynthesized quinone known 
to possess anti-inflammatory effects have shown it to aid the skin barrier repair/wound healing 
process [20]. Furthermore, the purine metabolism pathway showed increased signal intensities of 2 
metabolites and research has shown that non-adenine based purines promote cell proliferation and 
release growth factors, thus accelerating wound closure [21]. Other metabolites with raised signal 
intensities in the highlighted metabolic pathways in Table III have shown to improve the skin barrier 
repair/wound healing process by stimulating keratinocytes, inducing antioxidative responses or 
stimulating the biosynthesis of collagen [22–24]. Therefore, all these metabolites with elevated 
signal intensities in the wound site compared to the dermis are indicative of wound healing thus, 
supporting the lipid differences between the ROIs which may be used as biomarkers in the skin 
barrier repair/wound healing process. 
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Conclusion 
The novel combination of the use of an in vitro LSE model with MSI allowed an in depth molecular 
analysis of the skin barrier repair/wound healing process to be carried out. A number of lipids 
directly involved in the skin barrier repair/wound healing process were identified, indicating these as 
potential biomarkers for further study and eventual use within clinic. Validation of the identified 
species as time dependant biomarkers would assist in the determination of which stage of the skin 
barrier repair/wound healing process the wound is in. This would facilitate the provision of best 
treatment to patients with wounds. 
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Figure Legends 
Figure 1: Schematic diagram of the normal skin barrier repair/wound healing process from the 
inflammation stage leading to the proliferative stage and then the remodelling stage. 
Figure 2: MALDI-MS profiling within the m/z 400-1200 range for all three regions of interest in 
negative ion mode. A) Dermis, B) epidermis and C) wound Site. 
Figure 3: MSI of incision model 4 days post wounding showing the spatiotemporal distribution of 
three species across the tissue in positive ion mode. White and black arrows show the two wound 
sites in the image A) Bi-colour image of two distinct ion species in the epidermis (green = m/z 721.4) 
and dermis (red = m/z 725.4). H&E image of same sample, 4x magnification. B) MSI of 
spatiotemporal distribution of an ion species with m/z 751.6 value across the tissue, the colour 
intensity relates to signal intensity in a pixel location. 
Figure 4: PCA and PCA-DA scores plots obtained from data collected from all three regions of interest 
(dermis, wound site and epidermis) in positive and negative ion mode. (A) PCA scores plot in positive 
ion mode, (B) PCA-DA scores plot in positive ion, (C) PCA scores plot in negative ion mode and (D) 
PCA-DA scores plot in negative ion mode. Dermis (red), yellow (wound site), blue (epidermis) and 
green (wound site and epidermis). 
Figure 5: (A) PCA-DA scores plot and (B) PCA-DA loadings plot from the negative ion data 
representing all three regions of interest (dermis (red), yellow (wound site), blue (epidermis)). 
 
Table I: List of putative identification of ions from PCA-DA in negative ion mode in all three ROIs 
(dermis, wound site and epidermis) using LIPID MAPS structure database search (mass tolerance +/- 
0.02 Da). Phosphatidylcholines (PC), Phosphatidylethanolamines (PE), Phosphatidylserines (PS), 
Phosphatidylgylcerols (PG), Phosphatidic acids (PA), Phosphatidylinositols (PI), Triglycerides (TG), 
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Sphingomyelins (SM), Glucosylceramide (GlcCer), Galactosylceramide (GalCer), Diglycerides (DG), 
Ceramide (Cer), Ceramide 1-phosphates (CerP), Glycerophosphonocholines (PnG), Lactosylceramide 
(LacCer). 
Table II: List of putative identification of ions from MS/MS profiling in negative ion mode in all three 
ROIs (dermis, wound site and epidermis) using LIPID MAPS structure database search (mass 
tolerance for product ions +/- 0.4 mDa). 
Table III: List of identified metabolic pathways where metabolites changed in the wound site 
compared to the dermis based on the negative ion mode spectra.  
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Location m/z 
Theoretical 
m/z 
m/z 
error 
Putative Identification 
Dermis 
491.33 
491.3143 
0.0157 PA  
491.3531 
0.0231 Xeniasterol-a 
491.3742 
0.0442 1alpha,25-dihydroxy-11alpha-phenylvitamin D3 
504.36 
504.3460 
0.014 PC  
504.3460 0.014 
CerP  
504.39 
504.3460 0.014 
CerP  
504.3460 0.014 
PC 
505.35 
505.3171 
0.0329 2-deoxy-20-hydroxy-5alpha-ecdysone 3-acetate  
505.3899 
0.0399 (20R/S)-24-Hydroxy-19-norgeminivitamin D3  
533.38 
533.4212 
0.0412 DG  
533.4153 
0.0353 Torulene  
533.3848 
0.0048 Cholesteryl-alpha-D-glucoside  
533.4153 
0.0353 3,4-Didehydro-beta-carotene  
533.4153 
0.0353 3,4-Dehydrolycopene  
533.4153 
0.0353 1',2'-Dihydrochlorobactene 
534.38 
534.3565 
0.0235 PC 
534.3565 0.0235 
PE 
534.3565 0.0235 
LysoPE 
534.3953  
0.0153 11alpha-(4-dimethylaminophenyl)-1alpha,25-dihydroxyvitamin D3 
885.61 
885.6260 
0.016 PGS  
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885.6590 
0.049 PG  
885.71 
885.6978 
0.0122 TG  
Wound site 
478.39 
478.3902 
0.0002 Docosadienoylcarnitine  
478.4266 
0.0366 Cer  
716.59 
716.5600 
0.03 PC  
716.5600 
0.03 PE  
717.67 
717.6403 
0.0297 DG 
717.6555 
0.0145 22:2 Campesteryl ester  
742.59 
742.5756 
0.0144 PC 
742.5756 
0.0144 PE 
742.5756 
0.0144 PnC 
742.5475 
0.0425 Termitomycesphin A 
742.5839 
0.0061 GlcCer 
744.62 
744.5913 
0.0287 PC 
744.5913 
0.0287 PE 
887.79 
887.8073 
0.0173 TG 
Epidermis 
699.65 
699.6086 
0.0414 22:4 Cholesteryl ester 
699.6086 
0.0414 20:3 Stigmasteryl ester 
835.57 
835.5495 
0.0205 PG 
835.534 
0.036 PI 
861.79 
861.7917 
0.0017 TG 
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863.71 
863.7134 
0.0034 TG 
863.6770 
0.033 22:3-Glc-cholesterol 
863.6770 
0.033 20:2-Glc-Stigmasterol 
863.6770 
0.033 20:3-Glc-Sitosterol 
887.64 
887.6747 
0.0347 PG 
888.62 
888.6488 
0.0288 PC 
888.6699 
0.0499 PS 
888.6240 
0.004 Galbeta-Cer 
888.6418 
0.0218 LacCer 
889.62 
889.5812 
0.0388 PI 
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Location m/z 
Theoretical 
m/z 
m/z error Putative Identification Empirical formula 
Dermis 
504.2478 N/A N/A No identification N/A 
533.2899 N/A N/A No identification N/A 
701.4029 701.5127 0.1098 PA(18:0/18:1(11E)) C39H74O8P 
887.7372 887.5655 0.1717 PI(20:3(8Z,11Z,14Z)/18:0) C47H84O13P 
Epidermis 
835.6749 N/A N/A No identification N/A 
863.6806 N/A N/A No identification N/A 
889.571 N/A N/A No identification N/A 
Epidermis/Wound site 742.6473 742.5839 0.0634 Glcβ-Cer C42H80NO9 
Wound site 
478.3276 N/A N/A No identification N/A 
716.57 716.5236  0.0464 PE(16:0/18:1(11E)) C39H75NO8P 
788.5557 788.5447 0.011 PS(18:0/18:1(11E)) C42H79NO10P 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Pathway associated with metabolite change Number of metabolites changed in the pathway 
Biosynthesis of unsaturated fatty acids 3 
Ubiquinone biosynthesis 3 
Purine metabolism 2 
Arachidonic acid metabolism 1 
Phenylalanine metabolism 1 
Taurine metabolism 1 
 Propanoate metabolism 1 
Glutathione metabolism 1 
beta-Alanine metabolism 1 
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